Welspun Enterprises Files Q3 FY26 Deviation Statement for Convertible Warrants
Welspun Enterprises submitted its quarterly deviation statement for Q3 FY26, confirming no deviation in the utilization of Rs 1,000.00 crore raised through convertible warrants. The company received Rs 250.00 crore during the quarter, with remaining funds to be received upon warrant conversion within 18 months, while maintaining full regulatory compliance under SEBI guidelines.

*this image is generated using AI for illustrative purposes only.
Welspun Enterprises Limited has submitted its statement of deviation or variation for the quarter ended December 31, 2025, confirming no deviation in the utilization of proceeds from its convertible warrants issued through preferential allotment. The statement, filed under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was reviewed by the Audit Committee and Board of Directors at their respective meetings held on February 04, 2026.
Issue Details and Fund Raising
The company raised funds through convertible warrants with a total issue size of Rs 1,000.00 crore via preferential issue on October 15, 2025. During the quarter ended December 31, 2025, the company received Rs 250.00 crore, representing 25% of the issue size as subscription amount. The remaining 75% amounting to Rs 750.00 crore will be received upon exercise of conversion option by warrant holders within 18 months from the allotment date of December 01, 2025.
| Parameter: | Details |
|---|---|
| Total Issue Size: | Rs 1,000.00 crore |
| Date of Fund Raising: | October 15, 2025 |
| Amount Received: | Rs 250.00 crore |
| Amount Pending: | Rs 750.00 crore |
| Conversion Window: | 18 months from December 01, 2025 |
Fund Utilization and Allocation
The deviation statement confirms no utilization of issue proceeds during the quarter ended December 31, 2025. The funds are allocated for two primary objectives: Rs 750.00 crore for infusion into construction of a 6-lane partially elevated highway corridor from Pune to Shirur (NH-753F) in Maharashtra under DFBOT (Toll) mode with a 29-year concession period, and Rs 250.00 crore for general corporate purposes.
| Object: | Original Allocation (Rs crore) | Modified Allocation (Rs crore) | Funds Utilized (Rs crore) | Deviation Amount (Rs crore) |
|---|---|---|---|---|
| Highway Construction Project: | 750.00 | N.A. | N.A. | Nil |
| General Corporate Purpose: | 250.00 | N.A. | N.A. | Nil |
| Total: | 1,000.00 | N.A. | N.A. | Nil |
Regulatory Compliance and Monitoring
CRISIL Ratings Limited serves as the monitoring agency for the convertible warrants issue. The deviation statement indicates no deviation or variation in the use of funds raised, with no changes in terms of contract or objects requiring shareholder approval. Both the Audit Committee and auditors provided no adverse comments on the fund utilization during the quarter.
| Compliance Parameter: | Status/Details |
|---|---|
| Monitoring Agency: | CRISIL Ratings Limited |
| Deviation in Fund Use: | No |
| Shareholder Approval Required: | Not applicable |
| Audit Committee Comments: | None |
| Auditor Comments: | None |
Corporate Governance and Disclosure
The statement was signed by Nidhi Tanna, Company Secretary (ACS-30465), and submitted to BSE Limited and National Stock Exchange of India Limited on February 04, 2026. The company maintains transparency by hosting all relevant information on its website at www.welspunenterprises.com . The filing ensures compliance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, regarding quarterly reporting requirements for fund utilization.
Historical Stock Returns for Welspun Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.03% | +0.06% | +7.18% | +6.16% | +14.96% | +472.50% |


































